Antineoplastic is a class of medicine to restrain or kill tumor cells in the body. It plays an important role in comprehensive cancer treatment, particularly for disseminated tumor and leukemia that cannot be treated with surgery. Most current antineoplastics work by inhibiting DNA or RNA synthesis, or even damaging the structure of DNA. Antineoplastics can be divided into CCNSA (Cell cycle nonspecific drug) and CCSA (Cell Cycle Specific agents) according to their different effect on tumor cells in different stages of generation cycles. Both of them have a killing effect on bone marrow hematopoietic stem cells and other cells with a short growth cycle, as well as an inhibiting effect on the body''s immune response.
Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.
In 2019, the market size of Anti-Neoplastic Agents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Neoplastic Agents.
This report studies the global market size of Anti-Neoplastic Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Neoplastic Agents sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb Company
Baxter
Boehringer Ingelheim
Bayer
Teva pharmaceutical Industries
Johnson & Johnson
Merck
Pfize
Accord Healthcare
Lundbeck
AbbVie
Market Segment by Product Type
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Market Segment by Application
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Neoplastic Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Neoplastic Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Neoplastic Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.
In 2019, the market size of Anti-Neoplastic Agents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Neoplastic Agents.
This report studies the global market size of Anti-Neoplastic Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Neoplastic Agents sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb Company
Baxter
Boehringer Ingelheim
Bayer
Teva pharmaceutical Industries
Johnson & Johnson
Merck
Pfize
Accord Healthcare
Lundbeck
AbbVie
Market Segment by Product Type
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Market Segment by Application
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Neoplastic Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Neoplastic Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Neoplastic Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Neoplastic Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Chemotherapeutic Agents
1.3.3 Biological/Immunotherapeutic Agents
1.3.4 Personalized Medicine
1.4 Market Segment by Application
1.4.1 Global Anti-Neoplastic Agents Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Cancer Rehabilitation Centers
1.4.5 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neoplastic Agents Market Size
2.1.1 Global Anti-Neoplastic Agents Revenue 2014-2025
2.1.2 Global Anti-Neoplastic Agents Sales 2014-2025
2.2 Anti-Neoplastic Agents Growth Rate by Regions
2.2.1 Global Anti-Neoplastic Agents Sales by Regions 2014-2019
2.2.2 Global Anti-Neoplastic Agents Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Neoplastic Agents Sales by Manufacturers
3.1.1 Anti-Neoplastic Agents Sales by Manufacturers 2014-2019
3.1.2 Anti-Neoplastic Agents Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Neoplastic Agents Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Neoplastic Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-Neoplastic Agents Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Neoplastic Agents Price by Manufacturers
3.4 Key Manufacturers Anti-Neoplastic Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Neoplastic Agents Market
3.6 Key Manufacturers Anti-Neoplastic Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Chemotherapeutic Agents Sales and Revenue (2014-2019)
4.1.2 Biological/Immunotherapeutic Agents Sales and Revenue (2014-2019)
4.1.3 Personalized Medicine Sales and Revenue (2014-2019)
4.2 Global Anti-Neoplastic Agents Sales Market Share by Type
4.3 Global Anti-Neoplastic Agents Revenue Market Share by Type
4.4 Anti-Neoplastic Agents Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Neoplastic Agents Sales by Application
6 United States
6.1 United States Anti-Neoplastic Agents Breakdown Data by Company
6.2 United States Anti-Neoplastic Agents Breakdown Data by Type
6.3 United States Anti-Neoplastic Agents Breakdown Data by Application
7 European Union
7.1 European Union Anti-Neoplastic Agents Breakdown Data by Company
7.2 European Union Anti-Neoplastic Agents Breakdown Data by Type
7.3 European Union Anti-Neoplastic Agents Breakdown Data by Application
8 China
8.1 China Anti-Neoplastic Agents Breakdown Data by Company
8.2 China Anti-Neoplastic Agents Breakdown Data by Type
8.3 China Anti-Neoplastic Agents Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Neoplastic Agents Breakdown Data by Company
9.2 Rest of World Anti-Neoplastic Agents Breakdown Data by Type
9.3 Rest of World Anti-Neoplastic Agents Breakdown Data by Application
9.4 Rest of World Anti-Neoplastic Agents Breakdown Data by Countries
9.4.1 Rest of World Anti-Neoplastic Agents Sales by Countries
9.4.2 Rest of World Anti-Neoplastic Agents Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Hoffmann-La Roche
10.1.1 Hoffmann-La Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.1.4 Anti-Neoplastic Agents Product Introduction
10.1.5 Hoffmann-La Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.2.4 Anti-Neoplastic Agents Product Introduction
10.2.5 Amgen Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.3.4 Anti-Neoplastic Agents Product Introduction
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 Baxter
10.4.1 Baxter Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.4.4 Anti-Neoplastic Agents Product Introduction
10.4.5 Baxter Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.5.4 Anti-Neoplastic Agents Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Bayer
10.6.1 Bayer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.6.4 Anti-Neoplastic Agents Product Introduction
10.6.5 Bayer Recent Development
10.7 Teva pharmaceutical Industries
10.7.1 Teva pharmaceutical Industries Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.7.4 Anti-Neoplastic Agents Product Introduction
10.7.5 Teva pharmaceutical Industries Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.8.4 Anti-Neoplastic Agents Product Introduction
10.8.5 Johnson & Johnson Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.9.4 Anti-Neoplastic Agents Product Introduction
10.9.5 Merck Recent Development
10.10 Pfize
10.10.1 Pfize Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.10.4 Anti-Neoplastic Agents Product Introduction
10.10.5 Pfize Recent Development
10.11 Accord Healthcare
10.12 Lundbeck
10.13 AbbVie
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Neoplastic Agents Sales Channels
11.2.2 Anti-Neoplastic Agents Distributors
11.3 Anti-Neoplastic Agents Customers
12 Market Forecast
12.1 Global Anti-Neoplastic Agents Sales and Revenue Forecast 2019-2025
12.2 Global Anti-Neoplastic Agents Sales Forecast by Type
12.3 Global Anti-Neoplastic Agents Sales Forecast by Application
12.4 Anti-Neoplastic Agents Forecast by Regions
12.4.1 Global Anti-Neoplastic Agents Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-Neoplastic Agents Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-Neoplastic Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Chemotherapeutic Agents
1.3.3 Biological/Immunotherapeutic Agents
1.3.4 Personalized Medicine
1.4 Market Segment by Application
1.4.1 Global Anti-Neoplastic Agents Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Cancer Rehabilitation Centers
1.4.5 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neoplastic Agents Market Size
2.1.1 Global Anti-Neoplastic Agents Revenue 2014-2025
2.1.2 Global Anti-Neoplastic Agents Sales 2014-2025
2.2 Anti-Neoplastic Agents Growth Rate by Regions
2.2.1 Global Anti-Neoplastic Agents Sales by Regions 2014-2019
2.2.2 Global Anti-Neoplastic Agents Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-Neoplastic Agents Sales by Manufacturers
3.1.1 Anti-Neoplastic Agents Sales by Manufacturers 2014-2019
3.1.2 Anti-Neoplastic Agents Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-Neoplastic Agents Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Neoplastic Agents Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-Neoplastic Agents Market Concentration Ratio (CR5 and HHI)
3.3 Anti-Neoplastic Agents Price by Manufacturers
3.4 Key Manufacturers Anti-Neoplastic Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-Neoplastic Agents Market
3.6 Key Manufacturers Anti-Neoplastic Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Chemotherapeutic Agents Sales and Revenue (2014-2019)
4.1.2 Biological/Immunotherapeutic Agents Sales and Revenue (2014-2019)
4.1.3 Personalized Medicine Sales and Revenue (2014-2019)
4.2 Global Anti-Neoplastic Agents Sales Market Share by Type
4.3 Global Anti-Neoplastic Agents Revenue Market Share by Type
4.4 Anti-Neoplastic Agents Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-Neoplastic Agents Sales by Application
6 United States
6.1 United States Anti-Neoplastic Agents Breakdown Data by Company
6.2 United States Anti-Neoplastic Agents Breakdown Data by Type
6.3 United States Anti-Neoplastic Agents Breakdown Data by Application
7 European Union
7.1 European Union Anti-Neoplastic Agents Breakdown Data by Company
7.2 European Union Anti-Neoplastic Agents Breakdown Data by Type
7.3 European Union Anti-Neoplastic Agents Breakdown Data by Application
8 China
8.1 China Anti-Neoplastic Agents Breakdown Data by Company
8.2 China Anti-Neoplastic Agents Breakdown Data by Type
8.3 China Anti-Neoplastic Agents Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-Neoplastic Agents Breakdown Data by Company
9.2 Rest of World Anti-Neoplastic Agents Breakdown Data by Type
9.3 Rest of World Anti-Neoplastic Agents Breakdown Data by Application
9.4 Rest of World Anti-Neoplastic Agents Breakdown Data by Countries
9.4.1 Rest of World Anti-Neoplastic Agents Sales by Countries
9.4.2 Rest of World Anti-Neoplastic Agents Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Hoffmann-La Roche
10.1.1 Hoffmann-La Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.1.4 Anti-Neoplastic Agents Product Introduction
10.1.5 Hoffmann-La Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.2.4 Anti-Neoplastic Agents Product Introduction
10.2.5 Amgen Recent Development
10.3 Bristol-Myers Squibb Company
10.3.1 Bristol-Myers Squibb Company Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.3.4 Anti-Neoplastic Agents Product Introduction
10.3.5 Bristol-Myers Squibb Company Recent Development
10.4 Baxter
10.4.1 Baxter Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.4.4 Anti-Neoplastic Agents Product Introduction
10.4.5 Baxter Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.5.4 Anti-Neoplastic Agents Product Introduction
10.5.5 Boehringer Ingelheim Recent Development
10.6 Bayer
10.6.1 Bayer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.6.4 Anti-Neoplastic Agents Product Introduction
10.6.5 Bayer Recent Development
10.7 Teva pharmaceutical Industries
10.7.1 Teva pharmaceutical Industries Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.7.4 Anti-Neoplastic Agents Product Introduction
10.7.5 Teva pharmaceutical Industries Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.8.4 Anti-Neoplastic Agents Product Introduction
10.8.5 Johnson & Johnson Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.9.4 Anti-Neoplastic Agents Product Introduction
10.9.5 Merck Recent Development
10.10 Pfize
10.10.1 Pfize Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-Neoplastic Agents
10.10.4 Anti-Neoplastic Agents Product Introduction
10.10.5 Pfize Recent Development
10.11 Accord Healthcare
10.12 Lundbeck
10.13 AbbVie
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-Neoplastic Agents Sales Channels
11.2.2 Anti-Neoplastic Agents Distributors
11.3 Anti-Neoplastic Agents Customers
12 Market Forecast
12.1 Global Anti-Neoplastic Agents Sales and Revenue Forecast 2019-2025
12.2 Global Anti-Neoplastic Agents Sales Forecast by Type
12.3 Global Anti-Neoplastic Agents Sales Forecast by Application
12.4 Anti-Neoplastic Agents Forecast by Regions
12.4.1 Global Anti-Neoplastic Agents Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-Neoplastic Agents Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
